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                 Two hundred years ago at the age of 62, James Parkinson    
wrote a 66 page treatise entitled An Essay on the Shaking Palsy. He 
believed that he had identified a new ‘medical species’ that had ‘not yet 
obtained a place in the classification of nosologists’ (Parkinson, 1817).   
              As a young apothecary Parkinson had attended a course of 
evening lectures given by the eminent surgeon-anatomist, John Hunter 
and taken copious shorthand notes. Long after Hunter’s death in 1833, Dr 
John Parkinson collated his father’s notes and published them under the 
title of Hunterian Reminiscences, Being the Substance of a Course of 
Lectures on the Principles and Practice of Surgery Delivered by the Late 
Mr John Hunter.  
            In one of the transcripts the following case is reported: 
 
  A lady, at the age of seventy-one, had universal palsy: every part 
of the body shook which was not fully supported. The muscles of 
respiration were so affected, that respiration was with difficulty 
effected; but in sleep the vibratory motions of the muscles ceased, 
and the respiration was performed more equably: any endeavour of 
the will to alter these morbid actions increased them. 
 
       In Hunter’s opinion palpitations present only when an arm was 
totally at rest behaved differently from the trembling seen when a limb 
was not fully supported.  
 
         We will now never know what stimulated Parkinson to write his 
medical classic but perhaps the subliminal influence of his hero and 
fellow geologist was a factor. Probably unbeknown to Parkinson, John 
Hunter had earlier described a patient who may well have had the shaking 
palsy in his Croonian Lecture of 1776 (Hunter, 1837):  
 
Lord L---‘s hands are almost perpetually in motion, and he never 
feels the sensation in them being tired. When he is asleep his 
hands, &c. are perfectly at rest; but when he wakes, in a little time 
they begin to move.    
 
    
What did James Parkinson (1755–1824) describe ?   
 
                       Parkinson defined the shaking palsy as a nervous disorder 
characterised by a trembling of the limbs at rest, lessened muscular power 
and a stooped posture associated with a propulsive, festinant gait.  
                   Chapter 1 of The Essay concludes with six clinical vignettes. 
All the cases were men who had noticed the first signs of the malady 
between the age of 50 and 65 years. Case VI provides the most edifying 
description but Case I, which Parkinson had seen ‘several years back’ 
was probably the most carefully studied patient and the one he relied 
most heavily on in the collage at the start of the chapter. 
                    Parkinson emphasises that the weakness is specific and 
differs from that seen in other forms of palsy. Its onset is gradual and is in 
one patient attributed to the advancement of age rather than illness: 
 
So slight and nearly imperceptible are the first inroads of this 
malady, and so extremely slow is its progress, that it rarely 
happens, that the patient can form any recollection of the precise 
period of its commencement. 
    Slowly the weakness worsens leading to difficulties with dexterous 
activities such as holding a fork or pen:    
 
The submission of the limbs to the directions of the will can hardly 
ever be obtained in the performance of the most ordinary offices of 
life. The fingers cannot be disposed of in the proposed directions, 
and applied with certainty to any proposed point. 
 
 ‘The dictates of the will,’ he wrote, ‘are even, in the last stages of the 
disease, conveyed to the muscles… but their actions are perverted.’  
 
                    The tremor is coarse and on occasions violent and is always 
maximal when the limb is at rest. In Case III it affects the head which 
nowadays would raise suspicion of an essential or dystonic tremor. He 
notes that the tremor usually begins in one limb and then spreads to 
involve the other limbs over several years. Case VI informs Parkinson 
that he is able to interrupt the interminable shaking for a few minutes by a 
brief sudden voluntary movement of the affected arm.  
… he first perceived weakness in the left hand and arm, and soon 
after found the trembling commence. In about three years 
afterwards the right arm became affected in a similar manner: and 
soon after the convulsive motions affected the whole body, and 
began to interrupt the speech. In about three years from that time 
the legs became affected. 
 
The patient also mentions that at the age of 71 he had experienced a 
sudden onset of right-sided limb weakness which had temporarily 
abolished his tremor. As his strength returned over the ensuing weeks so 
did his shake. The patient’s attendant then adds that the trembling is 
sometimes evident even in the lighter stages of his master’s sleep.  
 
Parkinson clearly describes the characteristic festinant gait of the fully 
established case but there is no clear description of either start hesitation 
or freezing (blocking) of gait. 
 
Case VI-  On being asked if he walked under much apprehension 
of falling forwards? He said he suffered much from it; and replied 
in the affirmative to the question, whether he experienced any 
difficulty in restraining himself from getting into a running pace? It 
being asked if whilst walking he felt much apprehension from the 
difficulty of raising his feet, if he saw a rising pebble in his path? 
He avowed, in a strong manner, his alarm on such occasions; and it 
was observed by his wife, that she believed, that in walking across 
the room, he would consider as a difficulty the having to step over 
a pin. 
 
    Case II walks almost entirely on the soles of his feet and depends on a 
stick to avert falls. Case IV who had only been seen at a distance requires 
support by an attendant: 
 
 ‘…standing before him with a hand placed on each shoulder, until 
by gently swaying backward and forward, he had placed himself in 
equipoise; when giving the word, he would start in a running pace, 
the attendant sliding from before him and running forward, being 
ready to receive him and prevent his falling, after his having run 
about twenty paces.’ 
 
                    Parkinson also mentions profound fatigue in the legs and 
motor impatience in which the patient is compelled to walk around 
endlessly to assuage his tremor. He describes severe constipation 
requiring mechanical removal of the faeces and continuous drooling of 
saliva. He hints at depression (‘the unhappy sufferer’) and suggests that 
rheumatism can precede the trembling. In the terminal phase of the illness 
he reports that the speech is reduced to a slur and swallowing becomes 
difficult. The patient lies motionless, the limbs are contracted and there is 
incontinence of the sphincters. The patients’ last days are passed in a 
delirious state.  
                          His post-hoc review of the available literature in Chapter 
II is thorough and scholarly but somewhat surprisingly makes no mention 
of John Hunter’s observations. Parkinson credits François Boissier de 
Sauvages de Lacroix (1706–1767), a botanist and physician for having 
identified some key elements of the shaking palsy. Sauvages’ separate 
descriptions of tremor coactus and sclerotyrbe festinantem in   
Methodical Nosology (1763) corresponded to rest tremor and a propulsive 
or hurrying gait but he had failed to see them as part and parcel of a 
single syndrome. 
 
                     Parkinson’s prose is still easy to read and as refreshing as 
wine. In 1820 James Cooke, a physician to the London Hospital 
contended that ‘Mr Parkinson’s Treatise’ was ‘highly deserving’ of 
attention. John Elliotson, soon to become the Professor of Medicine at 
University College Hospital credited Parkinson with nearly all of his 
knowledge on the subject in a series of case reports purported to represent 
cases of paralysis agitans in the Lancet in 1830 and 1831. None of 
Parkinson’s findings were contested by the British medical establishment 
and his monograph attracted interest on the continent. It was almost as if 
his observations came as no surprise to anyone, yet nobody before him 
had put two and two together. 
                        In the year of Parkinson’s death Wilhelm von Humboldt  
(1767–1835), German statesman and humanity scholar wrote insightfully 
about his ‘special clumsiness’ and its effect on his handwriting 
(Horowski et al., 1995). Humboldt believed he was describing the motor 
deficits of senility whereas Parkinson considered the shaking palsy to be 
a medical disorder rather than an extreme version of normal ageing  
                         In 1868 in a clinical lecture on paralysis agitans at the 
Hôtel Dieu, Trousseau demonstrated to his class that the movements of 
one of his patients, when instructed to repetitively open and close his 
hand, became slower and slower (Trousseau, 1868). This observation 
underpinned the modern definition of bradykinesia (progressive reduction 
in speed and amplitude after 20 seconds of sequential finger taps) (Gibb 
and Lees, 1988). Trousseau also taught, ‘the intellect …gets weakened at 
last; the patient loses his memory, and his friends notice soon that his 
mind is not as clear, precocious caducity sets in’. 
                          Charcot had experienced some difficulty in obtaining a 
copy of Parkinson’s monograph. He acknowledged Parkinson’s 
‘descriptive and vivid definition’ but found it incomplete in some aspects  
and encouraged his students at the Salpêtrière to translate it into French:  
It will provide you with the satisfaction and knowledge that one 
always gleans from a direct clinical description made by an honest 
and careful observer. 
                        Charcot carried out a number of highly publicised studies 
on tremor including the mechanical recording of myographic curves. He 
also distinguished slowness of movement from weakness and was the 
first to insist upon muscular rigidity as a cardinal sign. In his Tuesday 
afternoon lectures he made the point that the tremor was the least 
handicapping of the motor symptoms and drew his students’ attention to 
the characteristic facial mask, wrinkled forehead and raised eyebrows  
(Charcot, 1872). He considered paralysis agitans a misnomer. The 
patients were not paralysed and tremor was not an invariable finding. On 
June 12 1888 he proposed ‘maladie de Parkinson’ as an alternative rubric 
emphasising that the disorder was a ‘nevrose’ without demonstrable 
pathology. 
                        James Parkinson was an early exponent of field neurology 
(clinical observation and diagnosis outside the consulting room). Two of 
his cases he met casually in the street and then questioned (Cases II and 
III) while Case V was only seen at a distance. Charcot also drew the 
attention of his students to the potential for instant neurological diagnosis 
of the shaking palsy in its fully established form: 
I have seen such patients everywhere, on the streets of Rome, of 
Amsterdam, in Spain; it is always the same picture. They can be 
identified from afar; you do not need a medical history. 
                 By the late 19th century, the disorder had more or less reached 
its modern state of clinical recognition. In 1882 Thomas Buzzard, one of 
a coterie of physicians who helped the National Hospital for the 
Paralysed and Epileptic in Queen Square to acquire an international 
reputation, published a collection of 25 lectures most of which had been 
delivered at the hospital. The one on paralysis agitans was duplicated 
without attribution and became the first article accepted by Brain on 
Parkinson’s disease (Buzzard, 1882).  
                              Buzzard endorsed Charcot’s view that although rest 
tremor was an important component of the shaking palsy it was not 
specific or invariable and that postural limb tremor and quivering of the 
lips could also be seen. He also drew attention to bradyphrenia: 
 
There is an aspect of marked mental hebetude, or at all events an 
extreme slowness of expression, so that it is difficult to elicit 
answers to questions about his history… Yet we contrive to get, in 
process of time, though the task is laborious, a fair amount of 
information from him. The face wears a peculiarly stolid 
expression. 
 
                        Buzzard believed that a piping voice was a distinctive 
feature of the shaking palsy and one that he compared to the voice 
affected by actors to transmit an appearance of senility to their audience.  
A gap of thirty five years then occurred before Brain published a second 
paper on the topic. Dr J. Ramsay Hunt began his article Progressive 
Atrophy of the Globus Pallidus (Ramsay Hunt, 1917) as follows: 
 
It is now a century since James Parkinson wrote his celebrated 
essay on the ‘shaking palsy’ and with the skill of a master outlined 
the chief clinical features of the disease which justly bears his 
name. There are few, if any contributions to medical literature 
which excel in exactness of observation and clarity of expression 
Parkinson’s original communication on paralysis agitans. 
  
                     Hunt believed that over the course of time the clinical 
syndrome described by Parkinson would be shown to be caused by a 
variety of pathological lesions including damage to the globus pallidus.  
Two or three years after Hunt’s paper the thousands of survivors of 
epidemic encephalitis lethargica with Parkinson’s syndrome stimulated 
debate as to whether Parkinson’s disease existed at all. At the Paris 
Neurological Association meeting of 1921 attended by several 
international authorities – including Kinnier Wilson – L’Hermitte and 
Cornil in their introduction to the published Proceedings summarised the 
key issue of the day (L'Hermitte F and Cornil, 1921): 
 
We must either admit that there exists in addition to multiple 
Parkinsonian syndromes, an authentic Parkinson’s disease with 
particular lesions and a characteristic evolution and 
symptomatology or we must say that there is no Parkinson’s 
disease just as there is no hemiplegic disease or pseudo-bulbar 
disease. 
   
             In 1955 the Guarantors of Brain funded a bicentenary volume to 
commemorate James Parkinson’s birth that included a gratefully received 
reprint of An Essay on the Shaking Palsy and essays by WH 
McMenemey, WG Greenfield and FMR Walshe (Critchley and 
McMenemey, 1955). In his introduction MacDonald Critchley showed 
that the debate in Paris as to whether Parkinson’s disease existed had 
moved on to some extent: 
One of the major developments in our attitude towards Parkinson’s 
disease has been the growth of a concept of Parkinsonism as a 
syndrome- a symptom-complex which may emanate from various 
causations. The ‘shaking palsy’ of James Parkinson is now looked 
upon as merely one representative (though still the most important) 
of a number of clinical events. 
  Walshe defended the shaking palsy as a syndrome distinguishable from 
other known causes of arkinsonism by history and examination alone 
(Critchley and McMenemey, 1955): 
 To ignore these differences in the interests of what is a false 
simplicity is not to make useful generalizations, but to blur the fine 
points of clinical discrimination and to regress to a lower level of 
observational precision. 
 
The Technological Add Ons. 
 
Histopathology 
In Chapter IV of The Essay Parkinson cautiously proposes the possible 
site of damage leading to the symptoms of the shaking palsy.   
A diseased state of the medulla spinalis, in that part which is 
contained in the canal, formed by the superior cervical vertebrae, 
and extending, as the disease proceeds, to the medulla oblongata.  
        As his monograph comes to an end Parkinson explains his main 
reason for writing up his observations: 
Before concluding these pages, it may be proper to observe once 
more, that an important object proposed to be obtained by them is, 
the leading of the attention of those who humanely employ 
anatomical examination in detecting the causes and nature of 
diseases, particularly to this malady.   
        When Parkinson described the shaking palsy pathology had not yet 
become the anchor for disease classification. In contrast to Alzheimer’s 
disease which emerged later from a single detailed clinico-pathological 
case report of Auguste. D presented at the South West German 
Psychiatric Association in Tübingen in 1906, the shaking palsy survived 
as a clinical syndrome for a century.  
                         No agreement concerning the pathological signature of 
Parkinson’s disease existed even after the report in 1912 of eosinophilic 
inclusions in the medulla oblongata (Lewy bodies) and the discovery by 
Tretiakoff in his doctoral thesis of moderate to severe nerve cell loss in 
the pars compacta of the substantia nigra. The influential studies of 
Hassler (Hassler, 1938) and Greenfield and Bosanquet (Greenfield and 
Bosanquet, 1953) would belatedly lead to acceptance of brainstem Lewy 
bodies as a pre-requisite for the post-mortem confirmation of Parkinson’s 
disease. More recently syndromes of dementia, visual pseudo-
hallucinations and primary cardiovascular autonomic failure have all 
been associated with Lewy body and Lewy neurite pathology. 
                           The development of more precise clinical diagnostic 
criteria in the 1980s and 90s capable of a higher degree of correlation 
with typical pathological findings derives from a determination to 
preserve the shaking palsy as a clinico-pathological entity within the 
growing quantity of neuropathologically distinct Parkinsonian syndromes 
(Gibb and Lees, 1988). Remarkably there had been no previous published 
reports of Parkinson’s pathology that included adequate clinical detail. 
The primacy of the physical sign of bradykinesia in the clinical diagnosis, 
and the re-affirmation of the fuzzy borderland between ageing-related 
tremor and Parkinson’s disease arose from this phase of clinico-
pathological research.  
                       These correlative brain bank studies also drew attention to 
what I have called ‘The Other Parkinson’s Disease’. These individuals 
fulfil pathological criteria for the diagnosis but differ substantially in their 
clinical presentation from the shaking palsy. They present at an older age 
with axial and bulbar symptoms and early falls (in the first five years). 
They have a more rapid deterioration. Some have executive and visuo-
spatial dysfunction at presentation and many go on to develop early 
autonomic dysfunction including orthostatic hypotension. Tremor is not 
prominent but if looked for carefully may be present in a finger or in the 
lips or chin. 
                         It seems likely that a biological interaction between the 
primary neurodegenerative process in Parkinson’s disease and the effects 
of ageing and cerebrovascular disease on non-dopaminergic structures is 
responsible for this ‘other Parkinsonism’.  
 
  Neurochemistry                       
                    The discovery in 1960 of severe depletion of dopamine in the 
corpus striatum stemming from new anatomical and chemical techniques 
was the sort of advance that Parkinson had hoped for (Ehringer and 
Hornykiewicz, 1960). The shaking palsy could now be classified as a 
striatal dopamine deficiency and even as a neurohumoral disorder. L-
dopa, the natural amino acid precursor of dopamine reduced motor 
handicap in almost all patients and also those with post-encephalitic 
Parkinsonism whereas the majority of patients with vascular 
Parkinsonism, the Westphal variant of Huntington’s disease, chronic 
manganism and Wilson’s disease and the atypical Parkinsonian 
syndromes (MSA-P, PSP-P, corticobasal degeneration and Parkinsonism 
due to abnormal iron accumulation) were only exceptionally improved in 
a sustained fashion. This provided the opportunity for a new clinical 
description of l-dopa responsive Parkinson’s syndrome and the  
physiological replacement of the diseased dopaminergic nigrostriatal 
bundle by cell-based therapies and neurotrophins remains an important 
therapeutic target in Parkinson’s disease research. 
 
Molecular Pathology and Genetics 
           The neuronal protein alpha synuclein is an important constituent of 
the Lewy body and rare mutations of the alpha synuclein gene have been 
associated with Parkinsonism and dementia (Spillantini et al., 1997). The 
autosomal dominant forms of Parkinsonism, including that resulting from 
the commoner mutation of dardarin, are clinically indistinguishable from 
the shaking palsy. These findings have led to the suggestion that 
abnormal aggregation of alpha synuclein might be important in causing 
cell death in Parkinson’s disease. On the basis of regional Lewy body and 
neurite distribution at autopsy, Braak and colleagues have suggested that 
Parkinson’s disease might start in the olfactory bulb or even the enteric 
nervous system and spread rostrally from nerve cell to nerve cell in the 
brain from the dorsal nucleus of the vagus and other medullary nuclei to 
involve the cerebral neocortex. This attractive hypothesis captured 
neurologists’ imagination and led to a search for clinical correlates. As a 
result REM sleep disorder, reduced sense of smell, constipation and 
depression have been proposed as risk factors for the shaking palsy.   
                          Unfortunately there are many exceptions to the classical 
spreading distribution of Lewy bodies and ten times more people have 
alpha synuclein pathology in their neurons than ever develop Parkinson’s 
disease (Gibb and Lees, 1988). It seems likely that the Lewy body is a 
protective mechanism created to shield the neuron from further toxic 
insults. To embrace a prodromal phase and a terminal dementia in the 
clinical definition of Parkinson’s disease will require a great deal more 
pathological research to confirm strong clinical correlation with extra 
nigral neuronal dysfunction.   
 
 Conclusions. 
                 Nosography reflects the history of medicine and what has 
emerged over the last two centuries is a Parkinsonian hybrid informed by 
clinical methods and patients’ accounts combined with basic and applied 
science (Aronowitz, 2001). Histopathological, neurochemical and 
molecular genetic technologies have given James Parkinson’s clinical 
syndrome a solidity that semiotics alone could never have achieved. R E 
Kendall in his attempt to define illness drew an analogy between 
established disease states and the furniture in an old house (Kendell, 
1975): 
 
 … each generation has acquired a few new pieces of its own but 
has never [fully] disposed of those it inherited from its 
predecessors, so that amongst the inflatable plastic settees and 
glass coffee tables are still scattered a few old Tudor stools, 
Jacobean dressers and Regency commodes, and a great deal of 
Victoriana. A logician would have started by defining what he 
meant by disease as a whole and then produced individual diseases 
by sub-dividing the territory whose boundaries he had thus defined. 
Medicine … proceeded the other way and started with individual 
diseases. 
 
                 As our notions of neurological disease continue to extend 
beyond the traditional clinico-pathological paradigm to embrace a more 
dynamic consideration of pathological events and chemical processes, 
neurologists may be forced more and more to fall back on classical 
clinical methods in which scrupulous observation and description is 
combined with modern techniques of longitudinal neuroimaging and 
laboratory biomarkers. Starting from scratch with an open mind may 
open up new vistas of understanding and finally lead to the cure that 
Parkinson hoped his essay would pave the way for. 
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